Anthony Muslin

Tony is a 10+ year veteran of the pharmaceutical R&D sector and, most recently, was the Head of the Diabetes and Cardiovascular Therapeutic Area at Sanofi. Prior to Sanofi, Tony was Executive Director and Head of Cardiovascular and Metabolism Research at Novartis. At Novartis and Sanofi, Tony led teams and functions that resulted in the approval of Entresto® and Praluent®, and that advanced over 10 molecules into clinical trials. Prior to working in the pharma industry, he was the Langenberg Distinguished Professor of Medicine and Director of the Center for Cardiovascular Research at Washington University School of Medicine. Tony holds an M.D. from Harvard Medical School and also served on the faculty of UCSF.